Produced in collaboration with Depression and Bipolar Support Alliance
Support for this patient education program was provided by Otsuka Pharmaceuticals,
Takeda Pharmaceuticals U.S.A., Inc. and Alkermes Pharmaceuticals
Major depressive disorder (MDD), even the toughest cases, can be treated.
In collaboration with the renowned Depression and Bipolar Support Alliance, this new educational program is specially designed for families managing MDD. Sign in to hear from leading clinicians and patient advocates about:
- Why it’s important to participate in the decisions with healthcare professionals
- How to bring up your concerns, questions, and preferences about medications
- When to speak up if a medicine isn’t working, or has really bad side effects
- The different risks and benefits of different MDD medicines
- Additional resources offered by pharmacies and advocacy groups
Watch now on demand
Michael E. Thase, MD
Perelman School of Medicine
Michael E. Thase, MD, is professor of psychiatry and director of the Mood and Anxiety Section in the department of psychiatry at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and directs the Mood Disorders Research studies at the Philadelphia Veterans Affairs Medical Center. Dr Thase’s research focuses on the assessment and treatment of mood disorders, including studies of the differential therapeutics of both depression and bipolar affective disorder. He has authored or co-authored 16 books, numerous scientific articles and book chapters, and is involved in several professional organizations that include the American Psychiatric Association, the American Society of Clinical Psychopharmacology, and the National Depression and Bipolar Support Alliance.
Megan Maroney, PharmD, BCPP
Monmouth Medical Center
Megan Maroney, PharmD, BCPP, is a clinical associate professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey, and a clinical pharmacy specialist in psychiatry at Monmouth Medical Center in Long Branch, New Jersey, where she works with adult and child/adolescent inpatient and outpatient psychiatry teams. Dr Maroney is one of the first pharmacists in New Jersey to be granted approval for collaborative practice. She is an active member of the College of Psychiatric and Neurologic Pharmacists (CPNP) and serves on their programming committee, and has published numerous manuscripts in publications that include the Annals of Pharmacotherapy and the Mental Health Clinician. She received her Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy.
Depression and Bipolar Support Alliance
Kevin M. Einbinder is vice president, communications and chapter relations, for the Depression and Bipolar Support Alliance (DBSA) national headquarters in Chicago, providing strategic oversight and management of communications, marketing, programming, and DBSA’s 200+ chapters located throughout the United States and Canada. In 2013, he established his consulting firm, ROI Advisory Solutions and as marketing director provides strategic services in the areas of marketing, social and digital media, business development, and training and development. Mr Einbinder was an adjunct communications instructor at 5 colleges and universities, and has served on the board of directors for 2 nonprofit health care organizations, which serve the mentally ill and provide adult care community services.